| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 0 | 682 | 1,145 | 1,224 | 1,292 | 1,285 | 1,170 | 1,306 | 1,160 | 1,139 | 1,077 | 1,020 | 969 | 1,070 | 1,020 | 1,040 | 1,056 | 1,047 | 1,041 |
| Expenses | 0 | 580 | 863 | 1,027 | 1,074 | 1,153 | 1,025 | 1,151 | 1,007 | 1,043 | 959 | 902 | 871 | 983 | 915 | 921 | 919 | 905 | 896 |
| EBITDA | 0 | 102 | 281 | 197 | 219 | 132 | 145 | 156 | 153 | 96 | 119 | 118 | 98 | 87 | 105 | 119 | 137 | 142 | 145 |
| Operating Profit % | 0 % | 15 % | 24 % | 16 % | 16 % | 10 % | 12 % | 11 % | 13 % | 8 % | 10 % | 11 % | 9 % | 7 % | 9 % | 11 % | 12 % | 13 % | 13 % |
| Depreciation | 0 | 22 | 32 | 31 | 30 | 31 | 31 | 31 | 30 | 30 | 32 | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 |
| Interest | 0 | 7 | 13 | 7 | 5 | 6 | 4 | 5 | 7 | 6 | 12 | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 |
| Profit Before Tax | 0 | 77 | 243 | 165 | 187 | 115 | 116 | 124 | 122 | 76 | 81 | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 |
| Tax | 0 | 23 | 75 | 54 | 58 | 46 | 36 | 40 | 30 | 23 | 24 | 22 | 17 | 22 | 17 | 21 | 26 | 28 | 25 |
| Net Profit | 0 | 54 | 168 | 111 | 129 | 69 | 79 | 84 | 92 | 52 | 58 | 58 | 39 | 29 | 49 | 59 | 69 | 74 | 75 |
| EPS in ₹ | 0.00 | 5.20 | 10.58 | 6.97 | 8.12 | 4.31 | 4.99 | 5.31 | 5.75 | 3.29 | 3.63 | 3.64 | 2.44 | 1.85 | 3.08 | 3.73 | 4.39 | 4.69 | 4.75 |
Jubilant Ingrevia
Jubilant Ingrevia
696.90
+0.25
(0.04%)
There are new updates from the company1 day ago
View
Market Cap
11,096.30 Cr
EPS
15.89
PE Ratio
40.00
Dividend Yield
0.72 %
Industry
Chemicals52 Week High
885.00
52 Week Low
535.20
PB Ratio
3.79
Debt to Equity
0.27
Sector
Specialty Chemicals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
Company News
View All News
Jubilant Ingrevia has issued commercial papers worth 500 million rupees. Commercial papers are short-term debt instruments used by companies to meet immediate funding requirements.
Jubilant Ingrevia Reports 54% Jump in Profit After Tax with Strong Specialty Chemicals Growth6 days ago
Jubilant Ingrevia delivered strong quarterly results with profit after tax rising 54% year-on-year to Rs 75 crore compared to Rs 49 crore in the same quarter last year. EBITDA grew 29% year-on-year to Rs 153 crore, while overall revenue remained stable at Rs 1,038 crore versus Rs 1,024 crore in the previous year. The Specialty Chemicals segment drove performance with 11% revenue growth and achieved its highest ever EBITDA of Rs 130 crore at 27% margin, growing 52% year-on-year. The Nutrition segment saw a 4% revenue decline due to lower niacinamide prices and shipment delays. Chemical Intermediates showed sequential improvement with 1.5% quarter-on-quarter revenue growth and EBITDA margin improving to 4.4%. The company benefits from anti-dumping duties imposed by the European Union on Chinese choline chloride products, creating new export opportunities. Management maintains confidence in reaching peak revenue potential of around Rs 6,500 crore by FY'27 from their Rs 2,000 crore investment program.
Jubilant Ingrevia Limited has fully redeemed its Commercial Paper worth Rs. 100 crores on the maturity date of July 31, 2025. The Commercial Paper, bearing ISIN INE0BY014383, was originally issued on June 6, 2025. The company informed stock exchanges BSE and NSE about the completion of the redemption process.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,101.50 | #1 1,57,518.30 | 71.58 | 13,387.50 | 6.91 | #1 2,096 | 18.69 | 67.25 | |
2,846.20 | 85,370.30 | 59.63 | 14,825.80 | 12.13 | 1,251 | 71.41 | 31.45 | |
3,436.20 | 37,628.00 | 60.54 | 4,737.00 | -25.09 | 523 | 70.37 | 42.90 | |
1,864.10 | 25,172.70 | 36.98 | 8,365.80 | -3.26 | 697 | -20.24 | 45.71 | |
4,895.50 | 23,916.80 | 69.66 | 2,393.10 | 12.83 | 289 | #1 128.91 | 47.15 | |
469.30 | 22,047.90 | #1 35.86 | 4,664.30 | 10.33 | 555 | 46.09 | 46.15 | |
4,645.90 | 19,903.20 | 51.10 | #1 15,339.40 | 10.81 | 479 | -37.72 | 37.57 | |
6,450.00 | 19,469.80 | 39.03 | 5,692.40 | #1 18.99 | 499 | 18.11 | 32.18 | |
1,641.60 | 16,926.50 | 41.91 | 2,248.17 | -8.77 | 424 | 18.04 | 21.39 | |
4,853.50 | 14,992.70 | 36.61 | 2,366.70 | 7.83 | 411 | 3.35 | 38.49 |
Forecast
Actual
Growth Rate
Revenue Growth
-13.21 %
Net Income Growth
-40.52 %
Cash Flow Change
18.17 %
ROE
-42.06 %
ROCE
-37.57 %
EBITDA Margin (Avg.)
-9.44 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 0 | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 |
| Fixed Assets | 0 | 1,805 | 1,798 | 1,846 | 2,539 | 2,581 |
| Current Assets | 0 | 1,424 | 1,765 | 1,818 | 1,780 | 1,853 |
| Capital Work in Progress | 0 | 65 | 174 | 525 | 331 | 525 |
| Investments | 0 | 50 | 6 | 8 | 16 | 37 |
| Other Assets | 0 | 1,458 | 1,819 | 1,880 | 1,846 | 1,889 |
| Total Liabilities | 0 | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 |
| Current Liabilities | 0 | 894 | 1,053 | 1,180 | 1,286 | 1,401 |
| Non Current Liabilities | 0 | 561 | 311 | 413 | 708 | 704 |
| Total Equity | -0 | 1,923 | 2,433 | 2,666 | 2,738 | 2,927 |
| Reserve & Surplus | -0 | 1,907 | 2,417 | 2,650 | 2,722 | 2,911 |
| Share Capital | 0 | 16 | 16 | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 73 | -36 | 35 | 6 | -9 |
| Investing Activities | 0 | 33 | -71 | -469 | -568 | -389 |
| Operating Activities | 0 | 112 | 453 | 463 | 430 | 508 |
| Financing Activities | 0 | -72 | -418 | 42 | 144 | -129 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 50.68 % | 50.92 % | 50.92 % | 51.03 % | 51.10 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 45.22 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.35 % | 6.58 % | 6.55 % | 7.22 % | 6.89 % | 7.12 % | 6.96 % |
| DIIs | 0.83 % | 0.96 % | 0.32 % | 0.14 % | 0.15 % | 0.17 % | 1.38 % | 4.90 % | 5.98 % | 6.73 % | 8.21 % | 11.18 % | 13.61 % | 14.09 % | 15.47 % | 15.99 % | 15.92 % | 21.80 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 16.76 % | 21.30 % | 27.18 % | 26.23 % | 27.31 % | 27.61 % | 26.71 % | 25.75 % | 25.72 % | 26.13 % | 24.11 % | 22.74 % | 20.63 % | 20.57 % | 19.47 % | 19.17 % | 19.13 % | 19.41 % |
| Others | 31.74 % | 26.82 % | 21.58 % | 22.60 % | 21.43 % | 20.75 % | 20.44 % | 17.87 % | 16.83 % | 15.66 % | 16.20 % | 8.26 % | 7.71 % | 7.32 % | 6.36 % | 6.47 % | 6.36 % | 6.60 % |
| No of Share Holders | 60,038 | 95,235 | 1,49,939 | 1,81,847 | 1,91,477 | 1,93,858 | 1,95,704 | 1,86,895 | 1,85,062 | 1,86,294 | 1,73,533 | 1,62,202 | 1,50,388 | 1,42,736 | 1,25,367 | 1,24,830 | 1,20,406 | 1,23,748 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 | 5 | 5 | 5 | 5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 1.39 | 1.1 | 0.77 | 0.72 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Aug 2025 |  Annual General Meeting | NA | 29 Aug 2025 | 754.40 | 696.65 |
| 31 Jul 2025 |  Quarterly Result Announcement | NA | 31 Jul 2025 | 818.85 | 810.60 |
| 25 Jul 2025 |  Dividend | ₹ 2.50 /share | 25 Jul 2025 | 718.00 | 819.20 |
| 13 May 2025 | Quarterly Result Announcement | NA | 13 May 2025 | 696.10 | 718.00 |
| 03 Feb 2025 | Dividend | ₹ 2.50 /share | 03 Feb 2025 | 659.30 | 697.65 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 711.10 | 659.30 |
| 22 Oct 2024 | Quarterly Result Announcement | NA | 22 Oct 2024 | 732.20 | 731.40 |
| 30 Aug 2024 | Annual General Meeting | NA | 30 Aug 2024 | 610.10 | 642.85 |
| 02 Aug 2024 | Dividend | ₹ 2.50 /share | 02 Aug 2024 | 519.65 | 612.55 |
| 09 Feb 2024 | Dividend | ₹ 2.50 /share | 09 Feb 2024 | 460.65 | 436.55 |
| 10 Aug 2023 | Dividend | ₹ 2.50 /share | 10 Aug 2023 | 422.00 | 433.05 |
| 10 Feb 2023 | Dividend | ₹ 2.50 /share | 10 Feb 2023 | 472.90 | 472.65 |
| 24 Aug 2022 | Dividend | ₹ 2.50 /share | 23 Aug 2022 | 464.15 | 476.15 |
| 11 Feb 2022 | Dividend | ₹ 2.50 /share | 10 Feb 2022 | 572.25 | 567.85 |
| 06 Aug 2021 | Dividend | ₹ 0.35 /share | 05 Aug 2021 | 571.85 | 610.15 |
| 01 Feb 2021 |  Change Of Name | NA | 01 Feb 2021 | 0.00 | 0.00 |
Announcements
Announcement under Regulation 30 (LODR)-Issue of Securities
1 day ago
1 day agoE-Mail To Shareholders Intimating About Deduction Of Tax At Source (TDS) On Final Dividend For FY 2024-254 days ago
4 days agoDisclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Transcript Of The Investors Conference
Call For The Quarter Ended June 30 20256 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication6 days ago
6 days agoIntimation Regarding Letter Dispatched To The Shareholders Of The Company For Annual Report Of The Company For FY 2024-256 days ago
6 days agoNotice Of 6Th Annual General Meeting Along With Annual Report For The Financial Year 2024-256 days ago
6 days agoReg. 34 (1) Annual Report.6 days ago
6 days agoNotice Of 6Th Annual General Meeting Along With The Annual Report For The Financial Year 2024-256 days ago
6 days agoBusiness Responsibility and Sustainability Reporting (BRSR)6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 01, 2025
Aug 01, 2025Audio Recording Of Investors Conference CallJul 31, 2025
Jul 31, 2025Redemption Of Commercial PapersJul 31, 2025
Jul 31, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2025
Jul 31, 2025Grant Of Stock OptionsJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 31, 2025
Jul 31, 2025Unaudited Financial Results For The Quarter Ended June 30 2025Jul 31, 2025
Jul 31, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On July 31 2025Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 23, 2025
Jul 23, 2025Board Meeting Intimation for The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2025Jul 23, 2025
Jul 23, 2025Commercial Paper Proceeds Utilisation Certificate For The Quarter Ended June 30 2025Jul 23, 2025
Jul 23, 2025Intimation Of Record Date For Maturity Of Commercial PapersJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesJul 23, 2025
Jul 23, 2025Intimation For Redemption Of Commercial Paper (CP)Jul 22, 2025
Jul 22, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedJul 22, 2025
Jul 22, 2025Record Date For Commercial Papers - September 15 2025Jul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesJul 18, 2025
Jul 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Jul 11, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 16, 2025
Jun 16, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 13, 2025
Jun 13, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedJun 06, 2025
Jun 06, 2025Intimation Of Repayment Of Commercial Paper (CP)Jun 06, 2025
Jun 06, 2025Intimation Of Record Date For Maturity Of Commercial PapersJun 06, 2025
Jun 06, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesJun 06, 2025
Jun 06, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
May 29, 2025Response To BSE In Reference To Mail Received On May 29 2025May 29, 2025
May 29, 2025Clarification sought from Jubilant Ingrevia LtdMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-RetirementMay 24, 2025
May 24, 2025Intimation Of Record Date For Maturity Of Commercial Papers
May 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 18, 2025
May 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 13, 2025
May 13, 2025Technical Indicators
RSI(14)
Neutral 31.44
ATR(14)
Less Volatile 27.99
STOCH(9,6)
Oversold 7.04
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -13.13
ADX(14)
Weak Trend 24.05
UO(9)
Bearish 40.78
ROC(12)
Downtrend But Slowing Down -10.65
WillR(14)
Oversold -91.04
Mutual Fund Holdings
Axis Multicap Fund Direct-Growth 
HDFC Innovation Fund Direct-Growth 
Motilal Oswal Multi Cap Fund Direct - Growth 
ICICI Prudential Regular Savings Fund Direct-Growth 
Bandhan Large Cap Fund Direct-Growth 
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
HDFC Nifty Smallcap 250 Index Fund Direct-Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth 
Kotak Nifty Smallcap 250 Index Fund Direct-Growth 
Groww Nifty Smallcap 250 Index Fund Direct - Growth About Jubilant Ingrevia
Jubilant Ingrevia Limited is a global integrated Life Science products and Innovative Solutions provider. Incorporated in 2019, the company serves Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers. It operates through three core segments: Speciality Chemicals, Nutrition and Health Solutions, and Life Science Chemicals. The company manufactures and supplies speciality intermediates, nutrition & health solutions, and life science chemicals through five facilities in India. Jubilant Ingrevia is the global largest producer of Niacinamide and among the top two manufacturers of Vitamin B3 globally. It serves over 1400 customers in more than 60 countries and offers custom research and manufacturing services. The company is part of the Jubilant Bhartia Group and became a separate entity following a demerger from Jubilant Pharmova Limited in 2021.
Chairperson NameShyam S Bhartia
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
